FDA Approved: REYVOW — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA granted original approval for REYVOW (lasmiditan) by Eli Lilly for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• REYVOW (Lasmiditan)

Snippet

ORIG AP for REYVOW (LASMIDITAN)